Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19108,915,1.08 [0.90-1.30],0.4181511243265158
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,18350,291,1.75 [1.26-2.41],0.0007599337313268
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21659,179,1.24 [0.83-1.87],0.2956507212138328
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13411,1091,1.33 [1.11-1.58],0.0017899189136974
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21614,134,1.51 [0.94-2.42],0.0853939970349073
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19156,96,2.03 [1.17-3.54],0.0120446054010266
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23086,133,1.50 [0.93-2.39],0.0930840927071823
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23072,89,1.18 [0.66-2.09],0.5798866352783065
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18655,72,2.18 [1.14-4.16],0.0180717858467373
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21918,132,1.58 [0.99-2.53],0.0569306714916927
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21873,87,2.09 [1.17-3.71],0.0121581620715662
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23191,69,1.59 [0.82-3.07],0.167645571611788
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23223,68,0.96 [0.50-1.85],0.8991658560502452
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23220,65,0.89 [0.45-1.74],0.7281625697911218
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,22720,61,0.87 [0.43-1.77],0.7101496477603656
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21599,438,1.11 [0.85-1.45],0.4257807676026786
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21297,136,1.19 [0.74-1.90],0.4728262216497381
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21481,320,1.06 [0.78-1.45],0.7020235038409286
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16691,102,0.86 [0.50-1.49],0.5951860332233805
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16653,64,0.92 [0.46-1.86],0.8255188933572198
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16991,402,1.11 [0.84-1.46],0.482937322311799
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17003,414,1.08 [0.82-1.43],0.5742120495320224
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9543,386,0.87 [0.65-1.17],0.3621064402609164
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7641,209,1.54 [1.06-2.25],0.0236209547896178
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16648,59,1.26 [0.61-2.58],0.5329505473414871
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19823,771,1.43 [1.17-1.75],0.0005674045355703
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21679,472,1.05 [0.81-1.35],0.7313984480338219
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22680,157,0.84 [0.54-1.30],0.423938637535692
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23279,152,1.10 [0.71-1.72],0.6618267261546387
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,22959,88,0.82 [0.46-1.48],0.5161138971106312
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23289,97,1.35 [0.78-2.34],0.287626198810382
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Stomach,23343,71,1.69 [0.89-3.22],0.1081351953658993
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,23102,296,0.99 [0.72-1.36],0.9317524934321304
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23323,102,1.28 [0.75-2.19],0.3710723816591088
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23328,85,1.05 [0.58-1.90],0.8744887868014625
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23241,59,0.85 [0.42-1.75],0.6641611663209926
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",23244,58,0.88 [0.42-1.81],0.7182462395923848
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,23182,147,1.00 [0.63-1.57],0.993844613278548
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23320,64,1.06 [0.53-2.10],0.8738507980185357
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,23204,175,0.88 [0.58-1.34],0.5556194456908152
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of breast,12179,44,0.59 [0.25-1.38],0.223471035850329
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Leiomyoma of uterus,12033,311,0.67 [0.48-0.92],0.0145656256931812
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21746,194,1.29 [0.87-1.91],0.201557929758788
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21205,352,1.76 [1.31-2.36],0.0001575120189839
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21205,352,1.76 [1.31-2.36],0.0001575120189839
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18633,574,1.25 [0.99-1.58],0.0611967150254105
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22716,59,1.59 [0.78-3.26],0.2014268165590717
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22995,63,1.31 [0.66-2.62],0.4372923977082533
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16852,1663,1.12 [0.97-1.30],0.1131616686524679
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21592,650,0.88 [0.71-1.09],0.2394775517446892
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20509,156,,
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21717,171,1.47 [0.97-2.23],0.0688269201912937
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20496,143,,
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21137,784,2.15 [1.76-2.63],1.4338976870778486e-13
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21111,758,2.09 [1.70-2.57],2.1118842244143635e-12
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21439,188,1.17 [0.76-1.79],0.474280921408413
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21438,187,1.17 [0.76-1.79],0.4744915560632637
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16670,1481,1.08 [0.93-1.26],0.3214159705992853
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15381,192,1.20 [0.80-1.80],0.3860128809399601
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16560,1371,1.09 [0.93-1.28],0.296968739294019
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15247,58,2.53 [1.23-5.18],0.0115416200933425
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15281,92,1.06 [0.59-1.89],0.8495517622418427
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,19104,543,1.15 [0.90-1.46],0.2616299082727278
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18723,162,1.08 [0.70-1.68],0.7264856613063059
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22970,113,1.04 [0.62-1.74],0.8918106776663759
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23029,84,1.00 [0.54-1.82],0.98870545155281
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21774,34,0.63 [0.24-1.60],0.3284131892267427
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23264,34,0.62 [0.24-1.59],0.3201306816023495
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18595,34,0.62 [0.24-1.58],0.3119582174198008
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Alcohol dependence,21783,43,1.18 [0.51-2.71],0.6931961486599509
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,21704,51,1.31 [0.61-2.82],0.486972626131803
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18597,36,1.16 [0.47-2.87],0.7428419522873568
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18822,261,1.16 [0.83-1.63],0.3902397074017245
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression,21869,231,1.00 [0.69-1.43],0.979191584085639
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression or dysthymia,18459,198,0.87 [0.59-1.29],0.4900388562520723
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18671,110,1.01 [0.60-1.70],0.9805039269415864
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Other anxiety disorders,21928,64,0.98 [0.50-1.94],0.9557254391861651
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,18965,1509,0.97 [0.84-1.13],0.7050872573651275
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16588,103,0.54 [0.31-0.95],0.0326166273687288
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23247,80,0.36 [0.20-0.67],0.0013054804301274
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22002,473,1.02 [0.79-1.31],0.8878154324509626
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,21665,136,0.80 [0.50-1.29],0.3671853075578668
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,21587,58,0.63 [0.30-1.31],0.2151999988987855
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23109,52,0.68 [0.32-1.46],0.3240830095907931
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22153,119,1.59 [0.97-2.62],0.0677821823458145
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,21689,160,1.04 [0.68-1.59],0.8659754050870444
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,22804,119,1.21 [0.74-1.98],0.4579290927265516
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22128,716,1.10 [0.89-1.35],0.384700000599336
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21518,106,1.38 [0.82-2.34],0.2272115652748358
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21853,441,1.02 [0.78-1.32],0.8984965837799073
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22950,79,0.50 [0.27-0.94],0.0311862145680052
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,22931,60,0.62 [0.30-1.26],0.1836660640519215
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,22775,121,0.76 [0.46-1.24],0.2702686986799034
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22471,426,0.84 [0.64-1.10],0.1991377021044569
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22303,258,0.71 [0.50-0.99],0.0465011499337508
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22106,61,1.06 [0.53-2.14],0.8686256913094634
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22182,137,0.68 [0.43-1.09],0.1111356927780658
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22152,107,1.31 [0.77-2.21],0.3193910668473559
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17860,262,1.03 [0.74-1.45],0.8455429107154157
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18216,618,1.07 [0.85-1.34],0.5585985844119605
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21928,305,1.77 [1.30-2.42],0.0002905546867659
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22918,81,7.65 [4.41-13.28],4.881256188289077e-13
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2631,81,5.34 [3.08-9.26],2.2548292501480748e-09
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20368,81,8.83 [5.01-15.54],4.5477536347787456e-14
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22344,143,1.08 [0.68-1.70],0.7495325456286343
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22279,78,1.19 [0.64-2.21],0.5793107117608447
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22403,78,1.07 [0.58-1.99],0.8216740899414999
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22652,96,1.37 [0.79-2.39],0.2615422842291107
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23247,143,1.04 [0.66-1.65],0.8629805491575714
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22109,110,0.87 [0.51-1.47],0.5970803821225756
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,14392,4623,1.17 [1.06-1.30],0.0028248117732669
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22379,98,0.75 [0.43-1.31],0.3164638902441884
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",15249,3240,1.15 [1.03-1.29],0.0171642421332249
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,15292,3283,1.21 [1.08-1.36],0.001080738942934
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12119,110,,
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20433,1849,1.28 [1.12-1.47],0.0002910886643415
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,19684,1100,1.23 [1.03-1.46],0.0190704912997436
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21935,350,1.88 [1.41-2.51],1.992534620308716e-05
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22290,705,1.63 [1.33-2.01],3.5399976137734043e-06
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23177,131,1.67 [1.04-2.68],0.0328825011583308
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19022,438,1.45 [1.11-1.89],0.0058131115784312
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20058,1498,1.31 [1.13-1.52],0.0004307630013103
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22189,137,1.45 [0.91-2.30],0.1168121617504657
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22411,282,1.08 [0.78-1.49],0.6493014173809506
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22170,118,1.14 [0.69-1.88],0.6188786310618444
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22171,119,1.19 [0.72-1.96],0.4978159450161517
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12123,114,1.15 [0.67-1.96],0.611043786794591
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17129,70,1.55 [0.80-3.01],0.1924126314174656
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,17232,173,1.35 [0.88-2.06],0.1662712030397583
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9103,145,1.28 [0.79-2.08],0.315587986802361
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9651,693,1.28 [1.02-1.62],0.0336357014129005
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,17153,94,1.22 [0.69-2.17],0.4959857172499954
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17184,125,1.14 [0.69-1.88],0.6165126999866712
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21682,297,1.43 [1.04-1.96],0.028332838152083
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22047,198,1.34 [0.91-1.98],0.1399516535476735
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22083,178,1.37 [0.91-2.06],0.1312026806918436
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22192,158,1.35 [0.87-2.08],0.1755421367354324
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21689,107,1.28 [0.76-2.18],0.3547689322045667
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21760,178,1.18 [0.78-1.78],0.4315144654308583
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21602,167,0.80 [0.53-1.23],0.3095651124167734
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21580,145,0.99 [0.63-1.56],0.976436100299966
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23061,139,0.91 [0.57-1.44],0.6786982768857619
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,21950,515,0.90 [0.70-1.15],0.395267332485712
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,21639,119,0.64 [0.39-1.07],0.0898753337518083
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17192,2175,0.90 [0.80-1.03],0.1211024078719245
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23178,77,0.92 [0.49-1.71],0.7864824581116936
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20750,264,1.25 [0.89-1.76],0.1930788385740065
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20722,236,1.28 [0.89-1.83],0.1816188026810712
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22051,289,0.98 [0.71-1.35],0.8875693239331831
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22042,280,1.00 [0.72-1.39],0.9808700650503092
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22608,552,0.95 [0.75-1.20],0.6486551109625049
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,22147,91,0.97 [0.55-1.72],0.9196396422111028
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,22197,141,0.86 [0.54-1.36],0.5145148612985302
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22407,351,0.94 [0.70-1.26],0.6738419309545088
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,22193,137,0.83 [0.52-1.33],0.4499971817112786
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7389,76,0.80 [0.41-1.55],0.5102737418585112
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20204,1144,0.76 [0.65-0.90],0.0014858145943987
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,21663,248,0.71 [0.50-1.01],0.059733817871589
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21715,300,0.81 [0.59-1.12],0.2077458984593205
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21715,300,0.81 [0.59-1.12],0.2077458984593205
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21634,868,0.76 [0.63-0.92],0.0039886669836237
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Asthma,15159,868,0.71 [0.58-0.87],0.0006657061694302
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14762,868,0.71 [0.59-0.87],0.0007845789859643
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15150,859,0.72 [0.59-0.87],0.0009124103375281
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22770,127,0.99 [0.61-1.61],0.9625201707244672
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,21679,99,0.88 [0.51-1.54],0.6622924287014895
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22867,99,0.89 [0.51-1.54],0.6687210964786686
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21672,92,0.72 [0.40-1.28],0.2592569715319271
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,20499,145,1.19 [0.75-1.88],0.4628379903317029
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,20653,299,1.15 [0.84-1.58],0.3912758774176847
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21637,136,0.86 [0.53-1.37],0.5165999703333091
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15061,6504,1.10 [1.00-1.20],0.0467533298845344
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22893,341,1.15 [0.85-1.55],0.3657531482453767
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23339,43,0.87 [0.38-2.02],0.7547539517718345
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,23341,39,0.92 [0.38-2.22],0.8530476785627248
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,22644,92,1.79 [1.02-3.15],0.0413522768291979
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22644,92,0.93 [0.52-1.66],0.8097481955559167
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23335,47,0.97 [0.44-2.17],0.945303550896162
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22652,100,0.73 [0.42-1.27],0.26769055272314
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22377,92,0.82 [0.46-1.46],0.504009956785654
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23231,60,1.11 [0.55-2.25],0.7718965926518102
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16470,344,1.53 [1.14-2.06],0.0047363296811511
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18714,2588,1.14 [1.01-1.28],0.0290872152303769
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,16530,404,1.11 [0.84-1.47],0.4551914812611229
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16969,843,0.91 [0.75-1.11],0.3575431261145712
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16215,89,1.81 [1.01-3.23],0.0454129768386411
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16410,284,1.21 [0.87-1.69],0.2484471489024156
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16209,83,0.58 [0.31-1.07],0.0789267466328183
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,16331,205,1.27 [0.87-1.86],0.221625797867749
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,16271,145,1.60 [1.01-2.52],0.0432856804564941
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23162,99,1.62 [0.94-2.77],0.0810305404165971
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,16272,146,1.32 [0.84-2.09],0.2291652512106438
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17117,991,1.26 [1.05-1.50],0.0132309377593618
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,23206,91,0.68 [0.38-1.22],0.1990513755388769
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,16614,488,1.14 [0.88-1.47],0.3108831986309137
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16355,229,1.01 [0.70-1.46],0.960745610452334
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23208,122,1.36 [0.84-2.21],0.2157394255915388
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,23193,78,0.80 [0.43-1.48],0.4714215746764869
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,19672,2085,1.04 [0.92-1.19],0.5010091833096364
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,18389,802,1.22 [1.00-1.49],0.0481600862645342
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,17725,138,1.35 [0.86-2.14],0.195578931613115
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,17697,110,0.61 [0.36-1.03],0.062061693344411
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18718,1131,0.95 [0.80-1.12],0.5325533544105461
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22262,770,1.37 [1.12-1.67],0.0021927771850597
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,17085,2347,1.00 [0.88-1.13],0.9650569725846504
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22986,46,0.62 [0.27-1.40],0.2493431337627661
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23277,60,0.88 [0.43-1.79],0.7159570772917447
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,21552,60,0.89 [0.43-1.82],0.7426103998240661
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21537,45,1.08 [0.47-2.47],0.853116271196233
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23198,143,3.38 [2.18-5.26],6.329738623029686e-08
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,21635,143,3.46 [2.21-5.39],4.7646421403747863e-08
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21625,133,3.68 [2.32-5.83],2.8957534454676672e-08
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22128,636,1.24 [0.99-1.54],0.057897650784159
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22119,627,1.24 [0.99-1.54],0.0603500630398028
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14868,130,1.12 [0.68-1.83],0.6557511314525373
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal stricture,22743,130,1.11 [0.69-1.80],0.6624048036597867
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14822,84,0.93 [0.51-1.72],0.8279677435597654
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15651,913,0.84 [0.69-1.01],0.0688423594200201
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14893,155,0.66 [0.42-1.03],0.0665486504626319
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15062,324,1.07 [0.79-1.47],0.6490497956575716
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,21214,291,1.12 [0.81-1.54],0.5035020407095068
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22846,98,0.76 [0.44-1.32],0.33123678640715
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14845,107,1.49 [0.88-2.52],0.1370292894901038
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14793,55,1.97 [0.95-4.06],0.067079281446263
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15711,973,1.02 [0.85-1.22],0.8592832571026173
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,15106,368,1.16 [0.86-1.54],0.3305059944921313
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22830,82,0.78 [0.43-1.43],0.4194478360284548
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,22438,126,1.42 [0.87-2.30],0.1583652922801712
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,22384,72,1.34 [0.71-2.54],0.3636020077608112
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21832,734,0.86 [0.70-1.06],0.1610722857237444
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,21698,600,0.74 [0.59-0.93],0.0096350640039522
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,21218,120,0.97 [0.59-1.60],0.9125423475400142
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21155,57,2.72 [1.35-5.50],0.0052911562759122
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,21174,76,1.19 [0.63-2.22],0.5927507459478814
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23151,76,1.19 [0.64-2.23],0.5787020554483495
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21821,348,1.27 [0.94-1.70],0.1162208815505364
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21549,76,1.41 [0.75-2.66],0.2905970132120546
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,21538,65,1.26 [0.63-2.50],0.5151375078439573
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21531,58,0.83 [0.40-1.71],0.6162598512968445
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21691,218,1.25 [0.87-1.82],0.2321920821967936
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,21682,209,1.30 [0.89-1.89],0.1780596544066639
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19588,1619,1.03 [0.89-1.19],0.6682485569978636
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22801,107,0.79 [0.47-1.34],0.3841869291401287
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22924,439,1.15 [0.88-1.49],0.31332063536791
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21228,625,1.04 [0.84-1.30],0.7090758776727748
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22275,393,0.94 [0.71-1.24],0.6685478125743338
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21952,70,0.87 [0.45-1.68],0.6827242985421917
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22165,283,1.08 [0.78-1.49],0.6582732750420084
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23023,98,0.97 [0.56-1.69],0.9261473069136968
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22996,71,0.86 [0.45-1.63],0.6391050073287525
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22983,58,0.85 [0.42-1.73],0.6568518850155298
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22903,80,0.83 [0.45-1.54],0.5580661462884726
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22901,78,0.85 [0.46-1.59],0.6159985641005812
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22532,47,0.92 [0.42-2.05],0.8420376414355415
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22854,369,1.15 [0.86-1.53],0.3490816364416457
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20717,114,0.67 [0.40-1.13],0.1325687065915863
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20706,103,1.31 [0.76-2.26],0.3272746638924581
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20673,70,1.24 [0.64-2.39],0.5277890857691265
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20830,227,1.02 [0.70-1.47],0.929210516967415
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20813,210,1.15 [0.79-1.69],0.4694162588228453
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15255,4481,0.89 [0.81-0.99],0.0265462297672122
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16856,2792,0.84 [0.75-0.95],0.0043316553037302
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20688,1310,0.98 [0.84-1.15],0.8357902443884775
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14246,182,0.99 [0.66-1.50],0.9756083617770174
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14657,593,1.00 [0.79-1.25],0.9758742354910652
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22815,176,1.05 [0.70-1.59],0.8001467689484051
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22820,160,1.07 [0.69-1.64],0.7749511248371534
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15719,1655,0.81 [0.70-0.94],0.0055543201006774
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",18278,1655,0.82 [0.71-0.95],0.0067335172068293
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14160,96,1.19 [0.68-2.07],0.5466836069296248
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22559,93,1.23 [0.70-2.17],0.4756749730474694
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14361,297,0.84 [0.61-1.16],0.2908991505234674
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14183,119,0.70 [0.42-1.16],0.1611736709292779
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14502,438,0.65 [0.49-0.85],0.0015813128321244
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23117,216,0.84 [0.58-1.22],0.3653204704883659
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14802,738,0.87 [0.70-1.07],0.1904121320232393
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14637,573,0.93 [0.73-1.18],0.5440701106865107
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15413,1349,0.86 [0.73-1.00],0.0548371264254278
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14159,95,0.60 [0.34-1.06],0.0786698891309771
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14365,301,0.61 [0.44-0.85],0.0031648222640348
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14142,78,1.00 [0.53-1.87],0.999277637787832
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14157,93,0.35 [0.19-0.62],0.0003556485342774
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14510,446,1.06 [0.81-1.38],0.6647425541591492
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14466,402,1.04 [0.78-1.37],0.8048796834717364
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17538,278,0.73 [0.53-1.02],0.0678304673509183
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22598,105,1.50 [0.89-2.55],0.1304867869018878
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22565,72,1.48 [0.78-2.81],0.2329002843610182
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19302,79,1.20 [0.65-2.23],0.5543325377104666
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19599,376,1.13 [0.85-1.50],0.4084498111790517
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20181,958,0.96 [0.80-1.15],0.6759864164546074
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19466,243,0.99 [0.70-1.41],0.9520741863811326
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19340,117,1.31 [0.80-2.17],0.2843889342148913
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19926,703,0.97 [0.79-1.20],0.7756428918964097
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19267,44,0.72 [0.32-1.66],0.4428511818572982
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19442,219,1.07 [0.74-1.54],0.7388416911611642
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19312,89,1.32 [0.74-2.36],0.3524914182764294
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19309,86,0.89 [0.49-1.60],0.6938466054440398
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19356,133,1.18 [0.73-1.89],0.4955185881388545
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19281,58,0.96 [0.47-1.97],0.9123546539226076
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19512,289,0.92 [0.66-1.27],0.6029085462035775
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19714,336,1.19 [0.88-1.60],0.2680239811984306
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19460,82,0.49 [0.27-0.91],0.0234778480701899
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19497,119,1.71 [1.04-2.81],0.0344197866974056
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19464,86,1.57 [0.87-2.83],0.1304051737203192
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19420,42,0.71 [0.30-1.65],0.4233230504514966
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19546,168,0.81 [0.53-1.24],0.3251471106458733
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19535,157,0.82 [0.53-1.27],0.3739460750783661
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19679,301,0.94 [0.69-1.29],0.7132307532560691
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19438,60,1.07 [0.53-2.18],0.84551331464732
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19479,101,0.91 [0.53-1.57],0.7405057139138254
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19520,142,0.66 [0.42-1.05],0.0807469163180622
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19428,50,1.23 [0.57-2.66],0.604002250736944
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19839,461,0.91 [0.70-1.18],0.4654634220347468
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19569,191,0.97 [0.65-1.44],0.8779481289536626
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19634,256,0.92 [0.65-1.29],0.6151652154771092
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20911,245,0.92 [0.65-1.32],0.6609896385480959
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21108,442,0.98 [0.75-1.27],0.8533025937181518
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20707,41,1.15 [0.49-2.70],0.7534965158518683
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20714,48,0.65 [0.29-1.45],0.2928445365844574
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20755,89,0.69 [0.38-1.24],0.2156800713123495
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16998,4122,1.08 [0.98-1.20],0.1228573135715385
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8993,870,1.18 [0.97-1.43],0.0964858203414751
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19567,298,8.80 [6.43-12.02],2.6574758309166403e-42
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19351,82,2.94 [1.61-5.38],0.000475627980963
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19617,66,9.60 [5.09-18.08],2.6139554931691547e-12
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19641,90,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19632,81,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22963,250,1.42 [1.01-2.00],0.0450009603534466
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22731,91,2.63 [1.51-4.59],0.0006781502769824
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22899,186,1.60 [1.08-2.38],0.0198571901081262
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22788,75,1.42 [0.76-2.66],0.2655404504510956
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,20379,1226,1.04 [0.88-1.22],0.6722137887109569
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,19267,114,1.37 [0.82-2.29],0.2299471048265988
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19249,96,0.64 [0.36-1.13],0.1261241680126438
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19529,376,1.37 [1.03-1.83],0.0296853242423509
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19297,144,1.06 [0.67-1.67],0.8090531316363219
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19901,748,0.90 [0.73-1.10],0.3121226492605432
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8621,498,1.14 [0.88-1.46],0.3155260938215691
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8194,71,1.05 [0.55-2.02],0.8825195696951923
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydrocele,8186,63,1.21 [0.61-2.38],0.5904515304367539
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8194,71,0.94 [0.49-1.79],0.8535720368148232
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8216,93,1.55 [0.88-2.70],0.1272328226783779
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8236,113,1.09 [0.65-1.83],0.7356756334984179
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12068,230,0.71 [0.49-1.04],0.0773067049663566
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11915,77,0.67 [0.35-1.28],0.2220251702640098
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11918,80,0.72 [0.38-1.36],0.3090053687605644
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11896,58,0.78 [0.37-1.63],0.5049093767464037
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12044,166,0.89 [0.57-1.38],0.5983985352178312
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11928,50,1.09 [0.49-2.43],0.8365966882460012
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11935,57,0.83 [0.39-1.75],0.6252783028655551
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11158,1831,0.86 [0.74-0.99],0.0411694600580447
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Endometriosis,9392,65,0.50 [0.25-1.02],0.057594276893646
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9379,52,0.43 [0.20-0.95],0.0364073058424477
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9821,494,0.78 [0.60-1.01],0.0604320612846363
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9433,106,0.72 [0.41-1.26],0.2555497394178504
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9813,486,0.77 [0.59-1.01],0.0586313513373099
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9479,152,0.84 [0.53-1.35],0.4753852243164446
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9553,226,1.00 [0.68-1.47],0.9802609507760924
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9344,17,0.42 [0.11-1.66],0.2173035772067342
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9375,48,1.01 [0.44-2.29],0.9843385614554874
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",12193,64,1.43 [0.71-2.88],0.3213773320424559
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,12195,59,1.29 [0.62-2.68],0.4984679700871931
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,12201,29,1.85 [0.65-5.27],0.2501013925195263
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",12199,33,1.71 [0.64-4.58],0.2847895769625355
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9402,75,0.69 [0.35-1.34],0.2676846917885948
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9381,54,1.30 [0.60-2.83],0.5084420086096493
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9396,69,0.76 [0.38-1.50],0.4257092446222348
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Irregular menses,12200,87,0.70 [0.38-1.30],0.260295262137318
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9521,194,0.78 [0.51-1.18],0.2420500759653205
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9417,90,0.78 [0.43-1.43],0.4207335753843478
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",12201,37,0.79 [0.31-2.02],0.6210899182892953
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9439,112,0.95 [0.55-1.63],0.8479692702491521
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9376,49,1.49 [0.66-3.39],0.3361702177932063
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9965,638,0.83 [0.66-1.05],0.1270519264627712
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22785,87,1.24 [0.69-2.22],0.4681202277619607
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19887,670,0.81 [0.65-1.00],0.0509240415886046
